This Activity Requires You To Leave myCME.

You are now leaving myCME and connecting to our educational partner. myCME does not control content, practices, or other policies of the site you are entering.

You are about to open a webpage that is outside of this educational content.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
This CME Activity has expired and is no longer available for credit.
Meeting Diagnostic Challenges in Alzheimer's Disease: Recent Onset of Symptoms Suggestive of Dementia

Meeting Diagnostic Challenges in Alzheimer's Disease: Recent Onset of Symptoms Suggestive of Dementia


Patient Case Study

Time to Complete

0.50 hours


December 12, 2012


December 12, 2013

Maximum Credits

0.50 / AMA PRA Category 1 Credit(s)TM

Accredited Provider

Sponsored by Albert Einstein College of Medicine of Yeshiva University. If you have any questions relating to the accreditation of this activity, please contact Mildred Adighiuzor at 718-920-6674.
Produced by Haymarket Medical Education
Commercial Supporter
Supported by an educational grant from Lilly USA, LLC. For further information concerning Lilly grant funding visit

Program Description

Contemporary understanding of Alzheimer’s disease (AD) has evolved, so that it is now recognized as representing a continuum from a preclinical stage to mild cognitive impairment and finally to dementia. Similarly, diagnosis is evolving, sometimes requiring an array of assessments from a simple medical history to advanced imaging technologies and the use of biomarkers, as we see in the case of an elderly actor who exhibits signs of possible dementia.

Intended Audience

Neurologists and other clinicians who manage the care of patients with possible Alzheimer's disease or other dementias.

Educational Objectives

After taking part in this educational activity, participants should be better able to:

  • Describe the new construct for understanding, diagnosing, and treating Alzheimer’s disease (AD)
  • Apply contemporary approaches to the diagnosis of AD
  • Identify the role of AD biomarkers in preclinical and clinical settings


David A. Wolk, MD
Assistant Professor
Department of Neurology
University of Pennsylvania
Assistant Director, Penn Memory Center
Philadelphia, PA

David A. Wolk, MD, has nothing to disclose.

Adam Fleisher, MD, MAS
Geriatric Neurologist
Associate Director of Brain Imaging
Banner Alzheimer’s Institute
Phoenix, AZ

Adam Fleisher, MD, MAS, is a consultant for Avid Radiopharmaceuticals, Eli Lilly and Co., Inc., and Merck & Co., Inc.

Gary J. Kennedy, MD
Director, Division of Geriatric Psychiatry
Montefiore Medical Center
Bronx, NY

Gary J. Kennedy, MD, has nothing to disclose.

Publishing Staff Disclosures

Jill Rovitzky Black and Melissa A. Johnson, Haymarket Medical Education (HME), have nothing to disclose with regard to commercial support.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Albert Einstein designates this enduring educational activity for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of approved and/or investigational uses of agents that are not indicated by the FDA. Albert Einstein College of Medicine of Yeshiva University, Lilly USA, LLC, and Haymarket Medical Education do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Albert Einstein College of Medicine of Yeshiva University, Lilly USA, LLC, and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


To obtain credit, a score of 70% or better is required. This CE is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the posttest survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on within your Profile/Exam History, which you can then access at any time.


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue